132 related articles for article (PubMed ID: 11302479)
1. Management of heparin allergy during pregnancy with danaparoid.
Harrison SJ; Rafferty I; McColl MD
Blood Coagul Fibrinolysis; 2001 Mar; 12(2):157-9. PubMed ID: 11302479
[TBL] [Abstract][Full Text] [Related]
2. An analysis of clinical outcomes of 91 pregnancies in 83 women treated with danaparoid (Orgaran).
Magnani HN
Thromb Res; 2010 Apr; 125(4):297-302. PubMed ID: 19656552
[TBL] [Abstract][Full Text] [Related]
3. On the prophylactic and therapeutic use of danaparoid sodium (Orgaran) in patients with heparin-induced thrombocytopenia.
Schenk JF; Pindur G; Stephan B; Mörsdorf S; Mertzlufft F; Kroll H; Wenzel E; Seyfert UT
Clin Appl Thromb Hemost; 2003 Jan; 9(1):25-32. PubMed ID: 12643320
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic use of danaparoid in high-risk pregnancy with heparin-induced thrombocytopaenia-positive skin reaction.
Myers B; Westby J; Strong J
Blood Coagul Fibrinolysis; 2003 Jul; 14(5):485-7. PubMed ID: 12851535
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic studies of dalteparin (Fragmin), enoxaparin (Clexane), and danaparoid sodium (Orgaran) in stable chronic hemodialysis patients.
Polkinghorne KR; McMahon LP; Becker GJ
Am J Kidney Dis; 2002 Nov; 40(5):990-5. PubMed ID: 12407644
[TBL] [Abstract][Full Text] [Related]
6. Safe anticoagulation with danaparoid in pregnancy and lactation.
Schindewolf M; Mosch G; Bauersachs RM; Lindhoff-Last E
Thromb Haemost; 2004 Jul; 92(1):211. PubMed ID: 15213864
[No Abstract] [Full Text] [Related]
7. Danaparoid: a review of its use in thromboembolic and coagulation disorders.
Ibbotson T; Perry CM
Drugs; 2002; 62(15):2283-314. PubMed ID: 12381232
[TBL] [Abstract][Full Text] [Related]
8. Successful use of danaparoid in treatment of heparin-induced thrombocytopenia during twin pregnancy.
Gill J; Kovacs MJ
Obstet Gynecol; 1997 Oct; 90(4 Pt 2):648-50. PubMed ID: 11770579
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of danaparoid compared with enoxaparin as deep vein thrombosis prophylaxis after hip replacement surgery.
Wade WE
Am J Orthop (Belle Mead NJ); 1999 Apr; 28(4):229-31. PubMed ID: 10220094
[TBL] [Abstract][Full Text] [Related]
10. Danaparoid sodium.
Acostamadiedo JM; Iyer UG; Owen J
Expert Opin Pharmacother; 2000 May; 1(4):803-14. PubMed ID: 11249517
[TBL] [Abstract][Full Text] [Related]
11. Alternative anticoagulation with danaparoid in two pregnancies in a patient with former heparin-induced thrombocytopenia (HIT), homozygous factor V Leiden mutation, a history of venous thrombosis and recurrent pregnancy losses.
Schindewolf M; Lindhoff-Last E
Thromb Haemost; 2008 Apr; 99(4):776-8. PubMed ID: 18392337
[No Abstract] [Full Text] [Related]
12. A comparison of danaparoid and warfarin for prophylaxis against deep vein thrombosis after total hip replacement: The Danaparoid Hip Arthroplasty Investigators Group.
Comp PC; Voegeli T; McCutchen JW; Skoutakis VA; Trowbridge A; Overdyke WL
Orthopedics; 1998 Oct; 21(10):1123-8. PubMed ID: 9801236
[TBL] [Abstract][Full Text] [Related]
13. Treatment of 51 pregnancies with danaparoid because of heparin intolerance.
Lindhoff-Last E; Kreutzenbeck HJ; Magnani HN
Thromb Haemost; 2005 Jan; 93(1):63-9. PubMed ID: 15630492
[TBL] [Abstract][Full Text] [Related]
14. [Danaparoid in pregnancy in cases of heparin intolerance - use in 59 cases].
Schindewolf M; Magnani HN; Lindhoff-Last E
Hamostaseologie; 2007 May; 27(2):89-97. PubMed ID: 17479171
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopenia.
Tardy-Poncet B; Tardy B; Reynaud J; Mahul P; Mismetti P; Mazet E; Guyotat D
Chest; 1999 Jun; 115(6):1616-20. PubMed ID: 10378558
[TBL] [Abstract][Full Text] [Related]
16. Heparin-induced thrombocytopenia type II: perioperative management using danaparoid in a coronary artery bypass patient with renal failure.
Westphal K; Martens S; Strouhal U; Matheis G; Lindhoff-Last E; Wimmer-Greinecker G; Lischke V
Thorac Cardiovasc Surg; 1997 Dec; 45(6):318-20. PubMed ID: 9477469
[TBL] [Abstract][Full Text] [Related]
17. Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis: a clinical outcome study.
Chong BH; Gallus AS; Cade JF; Magnani H; Manoharan A; Oldmeadow M; Arthur C; Rickard K; Gallo J; Lloyd J; Seshadri P; Chesterman CN;
Thromb Haemost; 2001 Nov; 86(5):1170-5. PubMed ID: 11816702
[TBL] [Abstract][Full Text] [Related]
18. Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial.
de Valk HW; Banga JD; Wester JW; Brouwer CB; van Hessen MW; Meuwissen OJ; Hart HC; Sixma JJ; Nieuwenhuis HK
Ann Intern Med; 1995 Jul; 123(1):1-9. PubMed ID: 7539233
[TBL] [Abstract][Full Text] [Related]
19. Successful use of heparinoids in a pregnancy complicated by allergy to heparin.
Taylor AA
BJOG; 2001 Sep; 108(9):1011-2. PubMed ID: 11563455
[No Abstract] [Full Text] [Related]
20. Ardeparin and danaparoid.
Dimens Crit Care Nurs; 2000; 19(4):13-4. PubMed ID: 11998151
[No Abstract] [Full Text] [Related]
[Next] [New Search]
